Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sphingolipid signaling pathway is a complex cellular network involving the synthesis, metabolism, and signaling functions of sphingolipids—lipids such as ceramide and sphingosine-1-phosphate (S1P) that act as bioactive molecules in many critical processes including apoptosis, cell growth, differentiation, senescence, and immune cell trafficking[1][6][7]. Sphingolipid metabolites like ceramide and S1P are generated from sphingomyelin and other precursor lipids by various enzymes (e.g., sphingomyelinase, ceramidase, sphingosine kinase), and they engage in multiple intracellular and extracellular signaling events. Notably, S1P serves as a ligand for a family of G protein-coupled receptors (S1PR1-5), while ceramide mainly acts through receptor-independent mechanisms[1][8][9]. Dysregulation of sphingolipid metabolism and signaling is implicated in cancer, cardiovascular, autoimmune, infectious, and neurodegenerative diseases[2][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingolipid signaling pathway.